title: [Diclonate P in rheumatoid arthritis].
abstract: Diclonate P (sodium diclofenac, Pliva, Zagreb) was used in the treatment of 74 patients with rheumatoid arthritis as the basic antirheumatic drug. Analgesic and antiinflammatory activity and good tolerance of three dosage forms (tablets, suppositories, ampoules) of diclonate P were established on a statistically significant basis. In some parameters the drug compares very favourably with its chemical analogs.
authors.forename: E S
authors.initials: ES
authors.lastname: Tsvetkova
authors.forename: Z S
authors.initials: ZS
authors.lastname: Alekberova
authors.forename: R M
authors.initials: RM
authors.lastname: Balabanova
authors.forename: M M
authors.initials: MM
authors.lastname: Ivanova
authors.forename: N V
authors.initials: NV
authors.lastname: Chichasova
authors.forename: E L
authors.initials: EL
authors.lastname: Nasonov
mesh_terms: D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D004008:Diclofenac / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D013488:Suppositories; D013607:Tablets
chemical_list: D003692:Delayed-Action Preparations; D013488:Suppositories; D013607:Tablets; D004008:Diclofenac
vernacular_title: Diklonat P pri revmatoidnom artrite.